Literature DB >> 24088043

PLS3 mutations in X-linked osteoporosis with fractures.

Fleur S van Dijk1, M Carola Zillikens, Dimitra Micha, Markus Riessland, Carlo L M Marcelis, Christine E de Die-Smulders, Janine Milbradt, Anton A Franken, Arjan J Harsevoort, Klaske D Lichtenbelt, Hans E Pruijs, M Estela Rubio-Gozalbo, Rolf Zwertbroek, Youssef Moutaouakil, Jaqueline Egthuijsen, Matthias Hammerschmidt, Renate Bijman, Cor M Semeins, Astrid D Bakker, Vincent Everts, Jenneke Klein-Nulend, Natalia Campos-Obando, Albert Hofman, Gerard J te Meerman, Annemieke J M H Verkerk, André G Uitterlinden, Alessandra Maugeri, Erik A Sistermans, Quinten Waisfisz, Hanne Meijers-Heijboer, Brunhilde Wirth, Marleen E H Simon, Gerard Pals.   

Abstract

Plastin 3 (PLS3), a protein involved in the formation of filamentous actin (F-actin) bundles, appears to be important in human bone health, on the basis of pathogenic variants in PLS3 in five families with X-linked osteoporosis and osteoporotic fractures that we report here. The bone-regulatory properties of PLS3 were supported by in vivo analyses in zebrafish. Furthermore, in an additional five families (described in less detail) referred for diagnosis or ruling out of osteogenesis imperfecta type I, a rare variant (rs140121121) in PLS3 was found. This variant was also associated with a risk of fracture among elderly heterozygous women that was two times as high as that among noncarriers, which indicates that genetic variation in PLS3 is a novel etiologic factor involved in common, multi-factorial osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24088043     DOI: 10.1056/NEJMoa1308223

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  72 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Bone: Role for PLS3 in X-linked osteoporosis revealed.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2013-10-22       Impact factor: 43.330

Review 3.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

4.  A novel frameshift deletion in PLS3 causing severe primary osteoporosis.

Authors:  Alice Costantini; Panagiotis Ν Krallis; Anders Kämpe; Emmanouil M Karavitakis; Fulya Taylan; Outi Mäkitie; Artemis Doulgeraki
Journal:  J Hum Genet       Date:  2018-06-08       Impact factor: 3.172

Review 5.  The genetics of bone mass and susceptibility to bone diseases.

Authors:  David Karasik; Fernando Rivadeneira; Mark L Johnson
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

6.  Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis.

Authors:  Nan Li; Dolores D Mruk; Chris K C Wong; Will M Lee; Daishu Han; C Yan Cheng
Journal:  FASEB J       Date:  2015-06-05       Impact factor: 5.191

Review 7.  Insights from exome sequencing for endocrine disorders.

Authors:  Christiaan de Bruin; Andrew Dauber
Journal:  Nat Rev Endocrinol       Date:  2015-05-12       Impact factor: 43.330

8.  Osteogenesis imperfecta mutations in plastin 3 lead to impaired calcium regulation of actin bundling.

Authors:  Christopher L Schwebach; Elena Kudryashova; Weili Zheng; Matthew Orchard; Harper Smith; Lucas A Runyan; Edward H Egelman; Dmitri S Kudryashov
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

9.  The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.

Authors:  Seyyedmohsen Hosseinibarkooie; Miriam Peters; Laura Torres-Benito; Raphael H Rastetter; Kristina Hupperich; Andrea Hoffmann; Natalia Mendoza-Ferreira; Anna Kaczmarek; Eva Janzen; Janine Milbradt; Tobias Lamkemeyer; Frank Rigo; C Frank Bennett; Christoph Guschlbauer; Ansgar Büschges; Matthias Hammerschmidt; Markus Riessland; Min Jeong Kye; Christoph S Clemen; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

10.  Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.

Authors:  Y Liu; D Ma; F Lv; X Xu; J Wang; W Xia; Y Jiang; O Wang; X Xing; W Yu; J Wang; J Sun; L Song; Y Zhu; H Yang; J Wang; M Li
Journal:  Osteoporos Int       Date:  2017-07-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.